| Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma T Philip, C Guglielmi, A Hagenbeek, R Somers, H Van Der Lelie, D Bron, ... New England Journal of Medicine 333 (23), 1540-1545, 1995 | 2958 | 1995 |
| High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma T Philip, JO Armitage, G Spitzer, F Chauvin, S Jagannath, JY Cahn, ... New England Journal of Medicine 316 (24), 1493-1498, 1987 | 914 | 1987 |
| IBMTR Severity Index for grading acute graft‐versus‐host disease: retrospective comparison with Glucksberg grade PA Rowlings, D Przepiorka, JP Klein, RP Gale, JR Passweg, ... British journal of haematology 97 (4), 855-864, 1997 | 809 | 1997 |
| Long-term survival and late deaths after allogeneic bone marrow transplantation G Socié, JV Stone, JR Wingard, D Weisdorf, PJ Henslee-Downey, ... New England Journal of Medicine 341 (1), 14-21, 1999 | 801 | 1999 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 794 | 2012 |
| Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised … RK Hills, S Castaigne, FR Appelbaum, J Delaunay, S Petersdorf, M Othus, ... The lancet oncology 15 (9), 986-996, 2014 | 732 | 2014 |
| Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors G Socié, JY Mary, A de Gramont, B Rio, M Leporrier, C Rose, P Heudier, ... The Lancet 348 (9027), 573-577, 1996 | 700 | 1996 |
| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ... Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002 | 663 | 2002 |
| Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among … RM Emanuel, AC Dueck, HL Geyer, JJ Kiladjian, S Slot, S Zweegman, ... Journal of clinical oncology 30 (33), 4098-4103, 2012 | 518 | 2012 |
| Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure M Duval, JP Klein, W He, JY Cahn, M Cairo, BM Camitta, R Kamble, ... Journal of clinical oncology 28 (23), 3730, 2010 | 512 | 2010 |
| Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de … D Blaise, M Kuentz, C Fortanier, JH Bourhis, N Milpied, L Sutton, JP Jouet, ... Journal of Clinical Oncology 18 (3), 537-537, 2000 | 453 | 2000 |
| Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia JL Harousseau, JY Cahn, B Pignon, F Witz, N Milpied, M Delain, B Lioure, ... Blood, The Journal of the American Society of Hematology 90 (8), 2978-2986, 1997 | 438 | 1997 |
| Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories RP de Latour, JY Mary, C Salanoubat, L Terriou, G Etienne, M Mohty, ... Blood, The Journal of the American Society of Hematology 112 (8), 3099-3106, 2008 | 433 | 2008 |
| Rituximab in B-lineage adult acute lymphoblastic leukemia S Maury, S Chevret, X Thomas, D Heim, T Leguay, F Huguet, P Chevallier, ... New England Journal of Medicine 375 (11), 1044-1053, 2016 | 355 | 2016 |
| Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia P Sujobert, V Bardet, P Cornillet-Lefebvre, JS Hayflick, N Prie, F Verdier, ... Blood 106 (3), 1063-1066, 2005 | 348 | 2005 |
| Administration of herpes simplex–thymidine kinase–expressing donor T cells with a T-cell–depleted allogeneic marrow graft P Tiberghien, C Ferrand, B Lioure, N Milpied, R Angonin, E Deconinck, ... Blood, The Journal of the American Society of Hematology 97 (1), 63-72, 2001 | 348 | 2001 |
| Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience L Ades, A Guerci, E Raffoux, M Sanz, P Chevallier, S Lapusan, C Recher, ... Blood, The Journal of the American Society of Hematology 115 (9), 1690-1696, 2010 | 347 | 2010 |
| Allogeneic marrow stem-cell transplantation from human leukocyte antigen–identical siblings versus human leukocyte antigen–allelic–matched unrelated donors (10/10) in patients … I Yakoub-Agha, F Mesnil, M Kuentz, JM Boiron, N Ifrah, N Milpied, ... Journal of clinical oncology 24 (36), 5695-5702, 2006 | 320 | 2006 |
| Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia SM Davies, NKC Ramsay, JP Klein, DJ Weisdorf, B Bolwell, JY Cahn, ... Journal of Clinical Oncology 18 (2), 340-340, 2000 | 303 | 2000 |
| Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia N Dhédin, A Huynh, S Maury, R Tabrizi, K Beldjord, V Asnafi, X Thomas, ... Blood, The Journal of the American Society of Hematology 125 (16), 2486-2496, 2015 | 301 | 2015 |
